Hims & Hers Health (HIMS) Cash from Investing Activities (2019 - 2026)

Hims & Hers Health (HIMS) reported Cash from Investing Activities of -$15.4 million for Q1 2026, up 52.9% on a YoY basis from -$10.1 million in Q1 2025, and up 81.54% sequentially from -$83.7 million in Q4 2025.

Hims & Hers Health (HIMS) Cash from Investing Activities (2019 - 2026) Analysis & Trends

Hims & Hers Health (HIMS) has 8 years of Cash from Investing Activities data on file, last reported at -$15.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities rose 52.9% year-over-year to -$15.4 million; the trailing twelve-month figure through Mar 2026 stood at -$1.0 billion (down 1452.89% YoY), and the FY2025 full-year result was -$1.0 billion, down 5280.92% from the prior year.
  • Cash from Investing Activities climbed to -$15.4 million in Q1 2026, from -$83.7 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $20.7 million in Q4 2023 to a low of -$887.4 million in Q3 2025.
  • A 5-year average of -$61.0 million and a median of -$4.5 million in 2024 frame the typical range for Cash from Investing Activities.
  • Across the five-year window, Cash from Investing Activities jumped 417.09% in 2024 and plunged 8421.2% in 2025, its largest moves.
  • Tracing HIMS's Cash from Investing Activities over 5 years: stood at $6.0 million in 2022, then surged by 244.74% to $20.7 million in 2023, then plunged by 183.14% to -$17.2 million in 2024, then sank by 386.32% to -$83.7 million in 2025, then jumped by 81.54% to -$15.4 million in 2026.
  • Business Quant data shows HIMS's Cash from Investing Activities at -$15.4 million in Q1 2026, -$83.7 million in Q4 2025, and -$887.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.06 Bn 87.19 Bn - -
2 Teva Pharmaceutical Industries 35.92 Bn 32.18 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.51 Bn 30.57 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.56 Bn 23.49 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 23.18 Bn 21.03 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 21.76 Bn 21.76 Bn - -
7 Viatris 20.28 Bn 18.48 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.75 Bn 16.43 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.63 Bn 12.21 Bn 785.00 Mn -60.00 Mn
10 Hims & Hers Health 6.77 Bn 6.01 Bn 396.79 Mn -15.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -15.45 Mn
Mar 31, 2026 -15.45 Mn
Dec 31, 2025 -83.68 Mn
Dec 31, 2025 -83.68 Mn
Sep 30, 2025 -887.40 Mn
Sep 30, 2025 -887.40 Mn
Jun 30, 2025 -21.09 Mn
Jun 30, 2025 -21.09 Mn
Mar 31, 2025 -32.80 Mn
Mar 31, 2025 -32.80 Mn
Dec 31, 2024 -17.21 Mn
Dec 31, 2024 -17.21 Mn
Sep 30, 2024 -10.41 Mn
Sep 30, 2024 -10.41 Mn
Jun 30, 2024 -4.47 Mn
Jun 30, 2024 -4.47 Mn
Mar 31, 2024 13.04 Mn
Mar 31, 2024 13.04 Mn
Dec 31, 2023 20.70 Mn
Dec 31, 2023 20.70 Mn